Market Report
Broker tips: Reckitt Benckiser, QinetiQ, EasyJet
JP Morgan has upgraded its view on shares of Reckitt Benckiser, with its analysts pointing to potential upside in the firm's earnings per share in fiscal year 2020 and the potential for shifts in the company's portfolio of assets to unlock value.
Investec upgrades EasyJet despite "disappointing" results
Analysts at Investec lifted their target price on shares of EasyJet, despite the company's "disappointing" (albeit in-line with guidance) results the day before in comparison to those from its peer group.
JP Morgan upgrades Reckitt Benckiser, sees scope for M&A in medium-term
JP Morgan has upgraded its view on shares of Reckitt Benckiser, with its analysts pointing to potential upside in the firm's earnings per share in fiscal year 2020 and the potential for shifts in the company's portfolio of assets to unlock value.
QinetiQ 'largely shielded' from UK short-cycle pressures, Berenberg upgrades
QinetiQ shares have been "disproportionately" affected by wider bearishness on the sector after the profit warning from peer Ultra Electronics, said Berenberg, upgrading to 'buy' from 'hold'.
Euromoney boasts strength in 'year of transition'
Business information and events group Euromoney Institutional Investor saw its revenue and profit rise comfortably in the 2017 financial year, it reported in its preliminary statement on Wednesday, with adjusted total revenue ahead 6% at £428. 4m.
Dealogic sale to boost Euromoney cash position
International business information and events group Euromoney Institutional Investor has reached a binding agreement to sell its minority equity stake in Dealogic, a provider of content and software solutions to financial firms, to Ion Investment Group for approximately $135m, it announced on Wednesday.
Pantheon International completes four new investments in October
Investment firm Pantheon International completed four new investments throughout the month of October, spreading £31. 4m pounds between three existing North American interests and a new commitment towards a US mid-market buyout fund.
SSP full-year profit up, announces £100m special dividend
SSP reported a rise in full-year profit on Wednesday as it announced a special dividend of around £100m, but said that like-for-like revenue growth next year is expected to drop slightly.
Biffa swings to first-half profit, declares maiden dividend
Waste management company Biffa, which floated last year, reported a rise in interim revenue on Wednesday as it swung to a profit and reaffirmed its expectations for the full year.
Europe open: Stocks edge higher with spotlight on Fed minutes, German Socialists
Stocks have begun the morning little changed despite the strong gains overnight on Wall Street, with traders waiting for the release of the minutes of the US Federal Reserve's last rate-setting meeting in the evening and monitoring the news-flow out of Germany.
Charles Stanley warns over regulatory changes
Wealth manager Charles Stanley posted a jump in interim profit on Wednesday but cautioned that it may struggle to meet current market expectations if it does not see a higher level of trading activity or other revenue increases in the second half.
Finsbury Food says trading in line, revenue up 4% in first four months
Cake and bread manufacturer Finsbury said on Wednesday that trading in the first four months of the year has been in line with expectations.
ScS hails strong start to the year
Sofa and flooring retailer ScS said on Wednesday that it has made a good start to the year.
PowerHouse reaches first milestone in waste-to-energy design
Waste-to-hydrogen production firm PowerHouse Energy has completed the pre-front-end engineering and design (pre-FEED) stage of its distributed modular gasification (DMG) system, marking the first major milestone in the design of the product.
Hill & Smith slips as road projects pushed back
Hill & Smith, the maker of road safety barriers and other road infrastructure, confirmed a number of UK road schemes had been diverted into 2018 but that it still expects to meet full year targets.
GlaxoSmithKline's ViiV gets FDA approval for HIV treatment
GlaxoSmithKline said on Wednesday that ViiV Healthcare, the global specialist HIV company it majority owns, with Pfizer and Shionogi as shareholders, has announced that the US Food and Drug Administration (FDA) has approved Juluca,.
Quiz posts 35% jump in revenue in first results since IPO
In its first trading update as an AIM-listed company, fashion brand Quiz reported a 35% jump in interim revenue, driven by growth across all of its channels.
Thomas Cook tumbles as weak UK overshadows results
Thomas Cook said it was on track to meet expectations this year but problems in the UK, the tour operator’s biggest market, overshadowed its annual results.
London open: Stocks edge up ahead of Budget; Thomas Cook tanks
London stocks edged tentatively higher in early trade on Wednesday as investors sifted through corporate releases ahead of the Autumn Budget.
Sage completes cloud transformation and promises 2018 acceleration
Sage Group kept revenue growth and margins above their annual target and said the launch of its Business Cloud software suite would enable it to "accelerate momentum" in 2018.